Tech Company Financing Transactions
Color Genomics Funding Round
Color Genomics closed a $80 million financing round on 8/18/2017. Investors included CRV, Emerson Collective and General Catalyst Partners.
Transaction Overview
Company Name
Announced On
8/18/2017
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1801 Murchison Dr. 128
Burlingame, CA 94010
USA
Burlingame, CA 94010
USA
Phone
Website
Email Address
Overview
Color provides a high-quality, physician-ordered, genetic test at a low cost. We include support for physicians, as well as genetic counseling as part of every purchase. Our goal is to expand physician-supported access to breast and ovarian cancer genetic risk information for every person, everywhere.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Elad Gil
VP - R & D
Alicia Zhou
Browse more venture capital transactions:
Prev: 8/18/2017: Color Genomics venture capital transaction
Next: 8/18/2017: Outdoor Voices venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs